The Core Longevity Plan is a four phase framework Core Aesthetics uses to plan cosmetic injectable treatment across five to ten years rather than across single appointments. The four phases, Foundation (years 0 to 1), Rhythm (years 1 to 3), Adjustment (years 3 to 7), and Reassessment (years 7 to 10 and beyond), describe how a patient’s treatment plan typically evolves as ageing continues, how the dosing approach adapts to individual response data, and when the plan benefits from pulling back to a fresh consultation rather than continuing on autopilot. The framework is descriptive of how Core Aesthetics works rather than prescriptive of how all cosmetic injectable care should work. Results vary between individuals.
Why a multi year framework matters
Most cosmetic injectable patients are introduced to the field one appointment at a time. The first treatment is presented as a single decision; the second treatment is presented as a single decision; the maintenance rhythm emerges by accumulation rather than by design. This works for some patients, but it has costs that become visible only over years.
The first cost is incremental drift. When each appointment is decided in isolation, small additions accumulate. The patient who started with a measured dose of anti-wrinkle treatment in the glabella may, five years later, be receiving treatment in five or six areas at higher cumulative doses, without ever having made an explicit decision to expand the scope. None of the individual decisions felt large; the cumulative outcome may not reflect what the patient would have chosen if the long term picture had been laid out at the start.
The second cost is missed evolution. A patient’s face changes over the course of cosmetic injectable treatment, partly because of ageing and partly because of the treatment itself. anti-wrinkle treatment over years can reduce baseline muscle activity. Filler treatment over years can change tissue elasticity in the treated areas. The dose and placement that suited the patient at year one may not suit them at year five. Without an explicit framework for reassessment, the treatment plan tends to ossify around what worked in the past rather than what would work now.
The third cost is loss of strategic optionality. The patient who has been on autopilot for several years may find that their face has been gradually committed to a particular trajectory by the cumulative pattern of treatment. Pulling back, dissolving, or significantly changing direction becomes harder both clinically and emotionally. A framework that builds in periodic reassessment preserves the patient’s ability to change direction.
The Core Longevity Plan addresses these three costs by making the long horizon explicit from the first consultation. The patient and the practitioner agree on a planning frame that extends beyond the next appointment. Decisions are made with reference to where the patient wants to be in five years, not just where they want to be next month.
Phase 1: Foundation (years 0 to 1)
The Foundation phase covers the first calendar year of cosmetic injectable treatment for a new patient. Its purpose is not to achieve a final aesthetic result. Its purpose is to gather the information that will make the next nine years of planning sound. Most of the clinical effort in the Foundation phase is going into establishing a baseline rather than into changing it.
Foundation phase activities typically include the initial consultation with full facial assessment and clinical photography, a first treatment that is deliberately conservative relative to what the patient might receive at a clinic optimising for maximum visible change, the two week review appointment that captures how the patient’s tissue actually responded, the second treatment (if indicated) calibrated to the response data from the first, and the development of a documented baseline that the rest of the plan will be measured against.
The Foundation phase is also when the patient learns whether Core Aesthetics is the right clinic for their long term care. Some patients discover during the Foundation phase that they would prefer a clinic with a faster pace, a more aggressive dosing approach, a wider range of services, or a different clinical philosophy. This is a normal outcome and the Foundation phase is the right time to identify it. Switching practitioners later is more disruptive than switching during the early stages.
What the Foundation phase explicitly does not try to do is produce a “finished” face within twelve months. Patients who arrive expecting a rapid transformation are recalibrated during the consultation. The pace is deliberate; the result at the end of year one is typically described as “subtle, settled, with a clear baseline established for what comes next” rather than as a dramatic visible change.
Phase 2: Rhythm (years 1 to 3)
The Rhythm phase covers years one through three. By this point the patient and the practitioner have enough data to identify the patient’s individual response patterns. anti-wrinkle treatment duration, filler longevity, bruising tendency, sensitivity to specific placements, and seasonal preferences are all known with reasonable confidence. The Rhythm phase translates this data into a sustainable maintenance pattern.
For most patients, the Rhythm phase settles into a treatment cadence that is more spaced than they were originally led to expect. Some patients move from quarterly anti-wrinkle treatment to a four month or even five month cadence as their muscle activity reduces with consistent treatment. Some patients move from annual filler treatment to an eighteen month or two year cycle as the cumulative volume reaches a sustainable level. The pace slows down as the plan settles in, not because anything has gone wrong but because the body responds increasingly predictably and the practitioner can plan with confidence.
The Rhythm phase is also when the documentation system becomes valuable. The clinic’s photographic record now spans multiple years, and small changes are visible in comparison that would not be visible in a single appointment view. The patient’s own documentation, notes after each treatment, photographs at home, observations about how the result wears, becomes a clinical input alongside the in clinic assessment. Patients who maintained documentation throughout the Foundation phase often find the Rhythm phase makes more interesting reading than they expected.
What can go wrong in the Rhythm phase is autopilot. The patient who books on a fixed schedule without ever revisiting the underlying plan may find that the treatment continues out of habit rather than out of clinical indication. Core Aesthetics builds an annual planning conversation into the Rhythm phase to interrupt this drift, a longer appointment, typically once a year, that steps back from “what does this appointment need” to “is the overall direction still right”.
Phase 3: Adjustment (years 3 to 7)
The Adjustment phase covers years three through seven. By this point the patient’s underlying anatomy has continued to age, bone resorption has progressed, fat pad redistribution has continued, skin elasticity has changed, even while the treatment has been compensating for some of these changes. The Adjustment phase is when the treatment plan typically needs to evolve rather than continue.
What evolves during the Adjustment phase varies between patients. Some patients find that an area that did not need filler at year one becomes appropriate to consider at year five (the temples and tear troughs commonly become relevant in this window). Some patients find that an area that was originally treated with filler is now better addressed with a different approach (for example, a small structural addition that compensates for fat pad loss elsewhere, rather than continued top up of the originally treated area). Some patients find that an area that worked well in early treatment now produces a less natural result because the surrounding anatomy has changed.
The dosing approach also typically evolves in the Adjustment phase. anti-wrinkle dosing for many patients can be reduced as the cumulative effect of consistent treatment reduces baseline muscle activity. Filler placement may shift from volume restoration in single areas to broader structural balancing across the lower face, the mid face, or the temple cheek transition. The treatment becomes more architecturally informed as the patient and the practitioner have more data to work with.
What can go wrong in the Adjustment phase is sticking to year one decisions when the body has moved on. Patients who continue to receive the same dose in the same areas for seven years sometimes find at year eight that the cumulative pattern no longer reads as natural. The Adjustment phase exists in part to prevent this by building in explicit reassessment of where the volume should now be sitting.
Phase 4: Reassessment (years 7 to 10 and beyond)
The Reassessment phase begins around year seven. This is when many patients benefit from pulling back to a comprehensive reassessment that resembles a fresh consultation rather than continuing the established maintenance pattern. The purpose is not to undo previous treatment; it is to confirm that the plan is still the right plan for the patient’s current life, current goals, and current anatomy.
A Reassessment conversation typically covers what has changed since the last comprehensive review (life events, health changes, medication changes, weight changes, work changes), what the patient now wants from cosmetic injectable treatment that is different from what they wanted at year one, what areas now feel out of balance with the rest of the face, what the patient is observing about their own ageing that they have not raised in standard appointments, and whether the maintenance rhythm is still serving them or has become a habit.
The Reassessment phase sometimes produces a recommendation to step back from active treatment for a period. Some patients benefit from a six month or twelve month pause to let the existing treatment settle and to see what their face looks like in its current baseline state. Some patients use the Reassessment as an opportunity to dissolve specific older filler that has integrated in ways that no longer serve them. Some patients use the Reassessment to consider whether continued cosmetic injectable treatment is the right choice at all going forward.
What the Reassessment phase explicitly does not do is automatically extend the existing plan for another decade. The plan is reviewed on its merits at the seven year mark, and the recommendation may be to continue, to modify, to pause, or to change direction substantially. Patients who feel that their cosmetic injectable treatment has become an automatic part of their life often find the Reassessment conversation surfaces questions they had not realised they were avoiding.
Documentation continuity across the four phases
The Core Longevity Plan depends on continuous documentation across the multi year horizon. A treatment plan that spans seven years cannot be guided by appointment level notes alone; the longer arc requires a documentation system that supports comparison across years rather than just across individual appointments.
Core Aesthetics maintains clinical photography for every patient at every appointment, with consistent angles and lighting where possible, plus annual baseline photographs in a more controlled setting. The clinical record includes notes on what was treated, what dose was used, where the placement sat, how the patient responded at the two week review, and how the result wore over the months that followed. This record is referred to at every subsequent appointment and forms the basis of the annual planning conversation in the Rhythm phase and the comprehensive Reassessment in the seventh year window.
Patients are also encouraged to maintain their own documentation across the multi year plan. The documenting treatment progress page describes a practical approach to patient side documentation that integrates with the clinic’s record. Patients who maintain their own notes and photographs find that the long horizon planning conversations are more substantive because the patient is bringing observations the practitioner cannot independently capture.
Documentation also matters for continuity if the patient ever needs to switch clinics. A patient who has been at Core Aesthetics for seven years has accumulated a clinical record that any future practitioner can use to understand the patient’s response patterns and treatment history. The record belongs to the patient and is provided on request. This is one of the more underrated benefits of practitioner continuity over a multi year plan.
The role of the conservative dosing principle
The Core Longevity Plan is built on the conservative dosing principle: lower doses, smaller volumes, fewer areas treated, and more deliberate intervals between treatments than is typical in clinics optimising for maximum visible change. The principle applies across all four phases and is particularly important during the Foundation phase when the patient’s response patterns are not yet known.
The clinical rationale for conservative dosing in a long horizon plan is that overshoot is more difficult to correct than undershoot. A treatment that produces less visible change than the patient anticipated can be supplemented at the two week review with minimal disruption. A treatment that produces more visible change than the patient anticipated typically cannot be reduced without either waiting for the result to wear off (which can mean months of feeling that the face does not look right) or, in the case of filler, performing a separate dissolution procedure with its own assessment and recovery requirements. Starting low preserves the patient’s optionality.
Conservative dosing also reduces the cumulative drift discussed earlier. A multi year plan built on smaller doses produces a cumulative trajectory that is easier to live with than a plan built on larger doses. Patients on the conservative approach typically reach their settled treatment rhythm within two or three years, with that rhythm being sustainable for many years thereafter. Patients on a more aggressive approach sometimes find that their face has been committed to a trajectory within the first eighteen months that is difficult to walk back from.
The conservative dosing principle is not about doing less for its own sake. It is about preserving the long horizon optionality that the four phase framework depends on. Patients who arrive expecting maximum volume treatment at every appointment may find that Core Aesthetics is not the right clinic for their preferences; this is a normal outcome of the consultation and is best identified during the Foundation phase rather than years later.
When the plan deliberately includes pulling back
A multi year plan that only ever adds is not a plan. The Core Longevity Plan explicitly includes the option of pulling back at every phase, and Core Aesthetics integrates pause and reset moments into the planning framework rather than treating them as failures.
Pulling back can take several forms. The simplest is a deliberate gap in treatment, a six month or twelve month period where no new treatment is performed, allowing existing treatment to wear off and the patient’s baseline to become visible. Some patients find these pauses clarifying; others find that the pause confirms they want to resume treatment. Both outcomes are useful information for the long term plan.
A more substantial pull back involves dissolving specific filler that has integrated in ways that no longer serve the patient’s current goals. The filler dissolution and reversal page covers this in detail. Dissolution is sometimes used as a corrective intervention for an over-treated area, and sometimes used as a strategic reset that allows a different treatment approach to be considered with a clean baseline.
The most substantial pull back is a comprehensive plan reset, typically considered during the Reassessment phase. This is a structured re evaluation that assumes nothing about the existing plan and asks the consultation stage questions again from scratch: what does the patient want, what does the assessment indicate, what intervention (if any) is appropriate. Some patients use a plan reset to confirm the existing direction; others use it to change direction substantially.
Building pull back options into the framework signals something about the clinic’s incentive structure. A clinic that benefits commercially from continuous escalation is unlikely to recommend pause and reset moments. A clinic that benefits from long term patient relationships is willing to recommend the reset that supports the relationship even when it reduces near term revenue.
How the plan adapts when life changes
A multi year cosmetic injectable plan needs to accommodate the fact that life changes. Patients who start the plan in their thirties may experience pregnancy, breastfeeding, menopause, significant weight changes, new medications, autoimmune diagnoses, bereavement, divorce, or major career changes during the seven to ten years the plan covers. The framework needs to be flexible enough to absorb these changes without falling apart.
Some life changes require a temporary pause. Pregnancy and breastfeeding are typically periods of no cosmetic injectable treatment, with the plan resuming after weaning at a reassessed baseline. Acute illness, certain medications, and certain surgeries also typically require deferral until the situation is stable. The Foundation phase covers most of these contingencies in the consent conversation; the Rhythm and Adjustment phases revisit them as they arise.
Some life changes warrant a recalibration of the plan rather than a pause. Significant weight loss or gain changes the underlying anatomy in ways that affect what placement and volume are appropriate. Menopause changes skin quality, fat distribution, and how the face responds to treatment. Some patients find that their priorities shift over years, the patient who valued specific aesthetic outcomes at year one may, by year seven, value a more general sense of looking well. The plan adapts to these shifts by revisiting the underlying goals during the annual planning conversation in the Rhythm phase and the comprehensive review in the Reassessment phase.
Some life changes warrant ending the plan altogether. Patients who reach a point where cosmetic injectable treatment no longer aligns with how they want to think about ageing, or where the time and financial commitment is no longer sustainable, are supported through a graceful exit. The clinic does not pressure continuation. The patient’s clinical record is provided on request. The conversation about ending treatment is conducted with the same care as the conversation about starting it.
How the framework is assessed at the practitioner level
A multi year plan depends on practitioner continuity. The same practitioner across seven or ten years builds a clinical understanding of the patient that no documentation system can replicate, recognising small changes from year to year, remembering what worked and what did not, knowing the patient’s communication style and what they actually mean when they describe a concern.
Core Aesthetics operates as a one practitioner clinic. Corey Anderson, AHPRA registered nurse (NMW0001047575), conducts every consultation and every treatment personally. Patients on the Core Longevity Plan are working with the same practitioner across the multi year horizon. This is structurally different from clinics that rotate patients between multiple practitioners or that treat injectable services as one of many revenue streams.
Practitioner continuity also matters for the consultation conversations that the framework depends on. The annual planning conversation in the Rhythm phase, the evolution discussions during the Adjustment phase, and the comprehensive Reassessment in year seven all benefit from the practitioner having been the one in the room across the previous appointments. A practitioner working from notes alone, without the embodied memory of the patient across years, has less to bring to these conversations.
What this means for patients considering Core Aesthetics for a multi year plan is that the practitioner’s availability becomes a planning variable. Patients should understand that one practitioner clinics do not scale infinitely; appointment availability sometimes requires booking weeks in advance. This is a tradeoff for the continuity benefit. Patients who value practitioner continuity highly typically find the planning constraint acceptable; patients who prioritise immediate availability may prefer a clinic with a different model.
What the framework does not promise
A multi year cosmetic injectable plan can support a healthier looking baseline as ageing continues. It can preserve the patient’s optionality across years. It can produce a settled treatment rhythm that fits into the patient’s life. It can build the documentation continuity that supports informed decisions over the long horizon. None of these are small things, and a well executed plan delivers all of them with reasonable consistency. Results vary between individuals; the framework describes the typical patient experience, not what every patient will encounter.
What the framework cannot promise is reversal of ageing. The bone resorption continues. The fat pad redistribution continues. The skin elasticity changes continue. Cosmetic injectable treatment supports a more balanced read of the face during ageing; it does not stop ageing or restore a younger face. Patients who expect the multi year plan to produce a face at year seven that looks younger than the face at year zero will be disappointed regardless of the technical quality of the treatment.
The framework also cannot promise universal applicability. Some patients’ faces, lifestyles, or expectations are not well suited to a multi year plan with conservative dosing and built in reassessment. Patients who want maximum visible change as quickly as possible may prefer a different clinic model. Patients who do not want to commit to a multi year planning relationship may prefer a transactional, appointment by appointment approach. The Core Longevity Plan is one approach among several; it is not the only valid way to think about cosmetic injectable treatment.
The framework also cannot promise that the plan will go exactly as anticipated. Life changes. Anatomy changes. The patient’s own goals change. The plan accommodates change but does not predict it. Patients who arrive expecting a rigid roadmap that will hold across ten years may find the framework’s emphasis on evolution and reassessment uncomfortable. Patients who appreciate that long term planning works best when it is responsive rather than fixed find the framework’s flexibility a feature rather than a limitation.
How to start working with the framework
Patients interested in the Core Longevity Plan begin with a consultation. The first consultation discusses the patient’s specific concerns, their treatment history (if any), their goals over the long horizon, and whether the framework aligns with how they want to approach cosmetic injectable treatment. The consultation does not commit the patient to anything; the patient may proceed, defer, or decide the framework is not right for them. All three outcomes are reasonable.
Patients who are already receiving cosmetic injectable treatment elsewhere can also engage with the framework. The first consultation in this case is partly a transition consultation: understanding what has been done, gathering whatever documentation the patient has from prior practitioners, performing a current state assessment, and discussing how the existing treatment fits or does not fit into a multi year plan going forward. Some patients in this situation choose to continue with their existing practitioner; others switch to Core Aesthetics; the choice is the patient’s.
Patients who are returning to cosmetic injectable treatment after a pause can use the framework to re enter thoughtfully. The first consultation in this case includes a discussion of why the pause happened and what the patient wants from this resumption. Some patients return with clearer goals than they had originally; others return wanting a more conservative approach than they used to have. The anxious about injectables page is sometimes useful here for patients whose pause was driven by uncertainty rather than by a specific reason. The framework adapts to where the patient currently is rather than requiring them to start from a clean slate.
Patients who are not ready to commit to a multi year plan can still benefit from the framework as a planning lens. The Foundation phase concepts apply to any first treatment, regardless of whether the patient ultimately stays for the Rhythm and Adjustment phases. The conservative dosing principle applies regardless of clinic. The documentation guidance applies regardless of the patient’s clinical relationship. Patients who read this page and decide they prefer a different clinic still have the framework concepts to take with them.
Clinical accountability and how this framework is reviewed
The Core Longevity Plan is written and maintained by Corey Anderson, AHPRA registered nurse (NMW0001047575) at Core Aesthetics in Oakleigh, Melbourne. Corey has been on the AHPRA Register of Nursing and Midwifery since January 1996. The framework reflects how Core Aesthetics actually operates with patients across multi year treatment relationships rather than describing an industry standard or a marketing concept. Results vary between individuals, and the framework is descriptive of the typical patient experience rather than prescriptive of what every patient will encounter.
The framework is reviewed periodically as AHPRA and TGA guidance evolves and as Core Aesthetics’ clinical experience accumulates. The September 2025 AHPRA cosmetic procedures guidelines required updates to the consultation stage components of the framework. Future guidance updates will be incorporated as they are published. The framework is not static; it adapts to current clinical and regulatory context while preserving the underlying four phase structure.
Patients reading this page who want to verify Corey Anderson’s AHPRA registration can do so directly on the AHPRA public register at ahpra.gov.au using registration number NMW0001047575. The Core Aesthetics clinic operates from 12A Atherton Road, Oakleigh VIC 3166, Tuesday to Saturday, by consultation appointment. All new patient treatment at Core Aesthetics follows a structured clinical consultation prior to any procedure. The CORE Method page describes the per treatment process methodology that operates within the longer horizon framework on this page; the two are complementary rather than competing. Patients with questions about the framework can raise them at consultation; the practitioner is happy to walk through any clinical reasoning that the written content does not fully capture.
Is this for you?
Consider booking a consultation if
- Patients who want to plan cosmetic injectable treatment over a multi year horizon rather than appointment by appointment
- Patients who value practitioner continuity and a one practitioner clinic relationship
- Patients comfortable with conservative dosing and built in reassessment moments across the plan
- Patients open to pausing, dissolving, or changing direction when the plan or the body changes
This may not be for you if
- Patients seeking maximum visible change as quickly as possible
- Patients seeking same day cosmetic injectable treatment without a separate consultation appointment
- Patients under 18 years of age
- Patients who prefer a transactional, appointment by appointment relationship without long term planning
- Patients seeking specific outcome assurances over a multi year horizon (no clinical practice can promise specific individual outcomes)
Suitability is confirmed at consultation. This list is general guidance, not a substitute for clinical assessment.
Frequently asked questions
Do I need to commit to ten years of treatment to use the framework?
No. The framework describes how multi year cosmetic injectable plans typically evolve, but no patient is asked to commit to a specific timeline. Patients can engage with the framework one phase at a time, can pause at any point, and can leave the plan if their priorities change. The framework is structured to support long horizon thinking, not to require it.
How is the Core Longevity Plan different from the CORE Method?
The CORE Method (Consult, Organise, Refine, Evaluate) is the per treatment process used at every appointment. The Core Longevity Plan is the multi year framework that the per treatment process operates within. The CORE Method governs what happens in a single appointment; the Core Longevity Plan governs how appointments connect across years. The two are complementary.
What if I am already several years into cosmetic injectable treatment elsewhere?
Patients with existing treatment history can engage with the framework starting from their current state rather than from a clean baseline. The first consultation in this case includes a transition discussion: understanding what has been done, gathering documentation, performing a current state assessment, and considering how the existing treatment fits into a multi year plan going forward.
Does the Foundation phase mean I have to wait a year for a substantial result?
No. The Foundation phase produces visible results, but those results are calibrated to be conservative and reversible rather than dramatic. Patients see settled visible change during the Foundation year; what the phase explicitly does not try to do is achieve a final aesthetic result within twelve months at the cost of long term optionality. The pace is deliberate.
What happens if I miss the annual planning conversation?
The annual planning conversation is recommended but not mandatory. Patients who miss it are not penalised, and the standard appointment cadence continues. The annual conversation is built in to interrupt autopilot, so missing it for a year is recoverable; missing it consistently for several years means the multi year planning intent of the framework is being lost.
Can I stop the plan at the Reassessment phase if I want to?
Yes. The Reassessment phase explicitly includes the option of ending active treatment, pausing for a defined period, or substantially changing direction. The clinic supports patients through plan exits with the same care as plan entries. The clinical record is provided on request. There is no pressure to continue.
How do I know if the framework is right for me?
The framework is appropriate for patients who want to think about cosmetic injectable treatment over a multi year horizon, who value practitioner continuity, who are comfortable with conservative dosing and built in reassessment, and who are willing to wait for a settled result rather than seeking maximum visible change quickly. Patients with different preferences may prefer a different clinic model. The first consultation is the appropriate place to assess fit.
Is the framework available in writing or only verbally at consultation?
The framework is documented on this page and discussed in detail at consultation. Patients receive a written record of the consultation that includes the recommendations specific to their situation. Patients are welcome to take notes during the consultation, request additional written materials, or follow up with questions after the appointment.